Skip to Content

In the Battle Against Zika, Researchers Prepare for a Marathon

The World Health Organization says Zika won’t succumb to a quick fix, even as scientists move forward on new ways of stamping it out.
November 21, 2016

The World Health Organization is no longer classifying Zika virus as an international public health emergency.

That’s not to say that it’s abated. Rather, the WHO is settling in for the long haul, deciding that the virus will be beaten by a steady, sustained effort—not quick fixes. “We are not downgrading the importance of Zika,” Pete Salama, executive director of WHO’s health emergencies program, explained to Science. “By placing it as a longer-term program of work, we are saying Zika is here to stay and WHO’s response is here to stay.”

The Zika virus causes only mild symptoms in those who contract it, and many never know they’re infected. But it has been linked to microcephaly, which means that pregnant women who contract the virus can give birth to children with severely shrunken heads and brains.

Genetically modified Aedes aegypti mosquitoes made by Oxitec were released in Piracicaba, Brazil, earlier this year.

Good news, then, that a proposal to release genetically engineered mosquitoes in Florida to fight the virus has finally been given the green light. The initiative seeks to test whether modified Aedes aegypti insects developed by the British company Oxitec can be effective in limiting the spread of Zika. Its mosquitoes, which are male, pass on a gene to their offspring that causes them to die before adulthood, causing the population of insects to plummet.

The U.S. Food and Drug Administration had already approved the trial, but a public vote earlier this month saw locals split on the issue. Mosquito control officials in Florida have decided to go ahead with the tests, though the final site for the experiment has yet to be confirmed.

Meanwhile, the New York Times reports that the quest to find a vaccine for the virus continues. In total, at least 12 companies are now working to develop a vaccine, as well as numerous academics and researchers at the National Institutes of Health and beyond.

Researchers are confident that they can make one. “Without being presumptuous, most of us in the field feel that we will get a vaccine for Zika,” Anthony S. Fauci, the director of the National Institute of Allergy and Infectious Diseases at the NIH, told the Times. And indeed, human trials have already begun.

The bad news is that nobody knows how long it will take to find one that's reliable. Clearly, the WHO thinks that it could take some time.

(Read more: Science, Stat, New York Times, “Zika Attacked an Unborn Baby’s Brain as Doctors Watched,” “Florida Vote Spells Uncertain Fate for Genetically Engineered Mosquitoes,” “U.S. Government Starts Test of Zika Vaccine in Humans”)

Keep Reading

Most Popular

VR is as good as psychedelics at helping people reach transcendence

On key metrics, a VR experience elicited a response indistinguishable from subjects who took medium doses of LSD or magic mushrooms.

This nanoparticle could be the key to a universal covid vaccine

Ending the covid pandemic might well require a vaccine that protects against any new strains. Researchers may have found a strategy that will work.

How do strong muscles keep your brain healthy?

There’s a robust molecular language being spoken between your muscles and your brain.

Stay connected

Illustration by Rose Wong

Get the latest updates from
MIT Technology Review

Discover special offers, top stories, upcoming events, and more.

Thank you for submitting your email!

Explore more newsletters

It looks like something went wrong.

We’re having trouble saving your preferences. Try refreshing this page and updating them one more time. If you continue to get this message, reach out to us at customer-service@technologyreview.com with a list of newsletters you’d like to receive.